Doctors run tests, scans look normal, yet the discomfort persists. A new wave of research is now mapping how sex hormones interact with intestinal cells and nerve messengers, providing a concrete biological explanation for these hard-to-pin-down digestive pains.
When hormones and the gut speak the same language
Chronic abdominal pain and irritable bowel syndrome (IBS) affect around one in ten people worldwide. Two-thirds of those patients are women. Their daily reality mixes cramping, bloating, alternating diarrhoea and constipation, and a constant need to plan life around a temperamental gut.
For years, many of these women were told their pain was “just stress” or a diet issue. Standard exams often show no inflammation, no obvious lesions, no tumour. Yet the pain is real, sometimes disabling, and very often linked to the menstrual cycle, pregnancy, or menopause transitions.
Patterns of pain that peak around ovulation, menstruation or late pregnancy point straight toward a hormonal trigger.
That clue led researchers, including a team led by physiologist Holly Ingraham at the University of California, San Francisco, to ask a simple question with complex consequences: how exactly do hormones like oestrogen interface with the digestive tract?
Oestrogen, mysterious gut cells and a pain cascade
Scientists initially suspected a well-known set of cells called enterochromaffin cells, the main producers of serotonin in the body. Serotonin, beyond its role in mood, carries pain and motility signals in the gut. If oestrogen acted directly on these cells, the story would have been straightforward.
It wasn’t. Tests showed that enterochromaffin cells did not respond directly to oestrogen in the way researchers expected.
The surprising role of L cells and peptide YY
The real breakthrough came when the team focused on a rarer type of intestinal cell: L cells, nestled in the lining of the colon. These cells are better known for their role in appetite and blood sugar control.
Under the microscope, L cells turned out to carry oestrogen receptors. When oestrogen levels rise, these receptors respond by pushing L cells to release a signalling molecule called peptide YY (PYY).
➡️ Boiling apple peels and cinnamon: why it’s recommended and what it’s for
➡️ This quick baked feta pasta became famous for a reason and the trick that makes it perfect
➡️ People Who Sleep With The Bedroom Door Closed Share These Personality Traits
➡️ A robot builds a 200 m² home in 24 hours : a breakthrough that could ease the housing crisis
Oestrogen does not cause pain directly. It launches a biochemical relay that primes the gut to overreact.
The sequence looks like this:
- Oestrogen levels increase, for example around ovulation or during certain phases of pregnancy.
- L cells in the colon detect this rise and release peptide YY.
- Peptide YY interacts with nearby enterochromaffin cells.
- Those cells respond by releasing serotonin.
- Serotonin activates nerve endings in the gut wall that carry pain and discomfort signals to the brain.
Through this chain reaction, a hormonal fluctuation becomes an amplified sensation in the belly. Foods or mechanical stretching that would barely register at another time suddenly feel like a serious threat.
Why women feel more gut pain than men
This mechanism helps explain why women, with naturally higher and fluctuating oestrogen levels, face a much higher burden of IBS and functional digestive disorders. Men also produce oestrogen, but at lower and more stable levels, making their intestines less vulnerable to these hormonal swings.
In women, several life stages can shift this hormonal-gut dialogue:
- Puberty: the onset of cyclical oestrogen production can coincide with the first episodes of unexplained gut pain.
- Pregnancy: soaring hormone levels may worsen IBS in some women, while easing it in others, depending on individual sensitivity.
- Perimenopause: erratic peaks and drops in oestrogen can make pain episodes more unpredictable.
The same hormone that prepares the body for reproduction can, in a susceptible gut, tip the balance toward hypersensitivity and chronic discomfort.
Food, bacteria and hormones: a three-way interaction
The story does not stop at hormones and nerve messengers. Diet and gut microbes sit right in the middle of this conversation.
How FODMAPs stir up the hormonal circuitry
Many people with IBS feel relief on a low-FODMAP diet, which restricts a category of fermentable sugars and fibres. Until recently, the link between such diets and pain reduction was poorly understood.
Research now suggests these fermentable carbohydrates are turned into short-chain fatty acids by gut bacteria. Those acids activate specific receptors, called OLFR78, on L cells in the colon.
Once those receptors are activated, the L cells again release peptide YY, restarting the PYY–serotonin–pain chain. In other words, a plate of onions, apples and wheat pasta can, through the microbiome, dial up the hormonal cascade and heighten discomfort.
| Element | Role in gut pain |
|---|---|
| Oestrogen | Triggers L cells to release peptide YY |
| L cells | Act as hormonal sensors and signal relays in the colon |
| Peptide YY (PYY) | Communicates with neighbouring cells, including serotonin-producing ones |
| Serotonin | Transmits pain and motility signals from the gut to the brain |
| FODMAPs & microbes | Produce acids that further stimulate L cells via OLFR78 receptors |
New treatment ideas: targeting the relay, not just the pain
Traditional gut pain treatments often try to block serotonin signalling. That strategy can help but comes at a cost: serotonin is crucial for mood, sleep and gut movement, so bluntly suppressing it raises the risk of side effects.
By mapping the hormonal relay in more detail, scientists are now eyeing earlier stages of the chain:
- Fine-tuning how L cells respond to oestrogen.
- Modulating peptide YY release instead of blocking serotonin outright.
- Designing drugs or dietary approaches that calm OLFR78 activation by bacterial metabolites.
Future IBS care could move from “one-size-fits-all antispasmodics” to personalised strategies that reflect sex, hormones and microbiome patterns.
Any attempt to interfere with oestrogen signalling must tread carefully, because those hormones act on bones, the heart, the brain and reproductive organs. The challenge for drug developers is to reach L cells in the gut without disrupting hormone action elsewhere.
What this means for patients in real life
For women living with unexplained digestive pain, this research brings something many have been waiting for: validation. Their symptoms are not imaginary, and not a simple reflection of anxiety or perfectionism. They arise from a measurable conversation between hormones, gut cells and nerves.
That knowledge can change the way symptoms are monitored and described in the clinic. Patients might track pain alongside their cycle, noting phases when discomfort spikes. Doctors, in turn, can look at IBS through a gender-specific lens, considering hormonal contraception, perimenopause or pregnancy as active factors in the symptom pattern.
Key terms worth understanding
- Peptide YY (PYY): a small protein made by intestinal cells that helps regulate appetite, gut movement and now, it seems, gut sensitivity.
- L cells: endocrine cells in the intestine that act as sensors for nutrients, bacteria and hormones.
- Short-chain fatty acids: compounds produced when gut bacteria ferment fibres and certain sugars; they are not always harmful, but in sensitive guts they may trigger pain circuits.
Imagine a typical month for a woman with hormone-sensitive IBS. During the follicular phase, when oestrogen rises, she starts noticing more bloating after meals that never used to be a problem. A few days before her period, pain peaks, sleep worsens, and the gut feels unpredictably fast or slow. Then, for a brief window, symptoms quieten before the next cycle resets the sequence.
Understanding that pattern as a biological cascade, rather than a personal failing or vague stress response, can itself reduce distress. Combined with a tailored diet, stress management, and potentially future drugs that tone down the L-cell relay, that knowledge offers a more hopeful roadmap for the many who live with hormone-amplified digestive pain.